Antibiotics 抗生素 PRODUCT NAME DESCRIPTION ß-Lactam Antibiotics Ampicillin Sodium Salt
50 μg/ml working concentration, interferes with formation of bacterial cell wall.
Ampicillin Trihydrate
50 μg/ml working concentration, interferes with formation of bacterial cell wall.
Carbenicillin Disodium Salt
0.1-30 μg/ml, synthetic derivative of Penicillin.
Penicillin G
100 U/ml working concentration, interferes with synthesis of bacterial cell wall.
Aminoglycoside Antibiotics G418 Sulfate (Geneticin)
400 μg/ml working concentration, an aminoglycoside similar to gentamycin.
G418 (Geneticin), 100 mM Solution
400 μg/ml working concentration, an aminoglycoside similar to gentamycin.
Gentamycin Sulfate
15 μg/ml working concentration, binds to the 30S subunit of bacterial ribosome.
Gentamycin Sulfate, 50 mg/ml Solution
15 μg/ml, binds to the 30S subunit of bacterial ribosome.
Hygromycin B
100 μg/ml working concentration, blocks peptide synthesis, inhibits chain elongation.
Hygromycin B, 50 mg/ml Solution
150 μg/ml, blocks peptide synthesis, inhibits chain elongation.
Kanamycin Sulfate
30 μg/ml working concentration, binds to the 70S subunit of bacterial ribosome.
Kanamycin Sulfate, 25 mg/ml Solution
30 μg/ml, binds to the 70S subunit of bacterial ribosome.
Kanamycin Sulfate, 50 mg/ml Solution
30 μg/ml working concentration, binds to the 70S subunit of bacterial ribosome.
Neomycin Sulfate
50 μg/ml working concentration, causes miscoding during protein synthesis.
Streptomycin Sulfate
30 μg/ml working concentration, binds to the 30S subunit of bacterial ribosome.
Tobramycin
1B1109 >900 μg/mg working concentration, inhibits Myeloperoxidase dependent oxidant
Antibiotics for Inhibition of Protein Synthesis Cycloheximide Erythromycin
100 μg/ml working concentration, inhibits protein synthesis at transpeptidation step.
Puromycin Dihydrochloride
50 μg/ml working concentration, inhibits protein synthesis.
Bacteriostatic Antibiotics Chloramphenicol
20 μg/ml working concentration, inhibits protein synthesis at peptidyltransferase.
Chlortetracycline Hydrochloride
15 μg/ml working concentration, inhibits transfer of activated amino acids to growing polypeptide chain.
Tetracycline Hydrochloride
15 μg/ml working concentration, blocks the binding of tRNA to the 30S subunit.
Tetracycline HCl, 50 mg/ml Solution
15 μg/ml working concentration, blocks the binding of tRNA to the 30S subunit.
Polyene Antifungal Antibiotics Amphotericin B .
2.5 μg/ml working concentration, alters membrane permeability
Amphotericin B, 250 mg/ml Solution
2.5 μg/ml working concentration, alters membrane permeability.
Nystatin Polypeptide Antibiotics Actinomycin D
1 μg/ml working concentration, complexes with DNA, inhibits RNA synthesis.
Bacitracin Zinc
>40 μg/ml working concentration, inhibitor of protein disulfide, and a peptide inhibitor.
Polymixin B Sulfate
300 U/ml working concentration, interferes with cytoplasmic membrane.
Other Antibiotics D-Cycloserine
100 - 200 μg/ml working concentration, inhibits cell wall biosynthesis.
Mitomycin C
25 μg/ml working concentration, inhibits nucleic acid synthesis.
Monensin Sodium Salt
500 μg/ml working concentration, inhibitor of DNA synthesis.
Mycophenolic Acid
25 μg/ml working concentration, inhibits Inosinate dehydrogenase.
Nalidixic Acid
15 μg/ml working concentration, inhibits DNA gyrase.
Plicamycin (Mithramycin) Streptozotocin
Selection agent, mutagenic agent, and a diabetes inducer.
Vancomycin Hydrochloride
3 μg/ml working concentration, amphoteric glycopeptide.
Antibiotic Cocktails Penicillin/Streptomycin
10,000 U Penicillin and 10 mg/ml Streptomycin when reconstituted in 20 ml of sterile dH2O.
Penicillin/Streptomycin/Amphotericin B
10,000 U Penicillin, 10 mg Streptomycin and 250 μg/ml Amphotericin B when reconstituted in 20 ml of sterile dH2O.
Penicillin/Streptomycin/Neomycin
5,000 U Penicillin, 5 mg Streptomycin and 10 mg/ml neomycin when reconstituted in 20 ml of sterile dH2O.
Penicillin Streptomycin, 100X Solution
10 ml/L working concentration, cell culture application.
A Brief Biodata of Prof. Mosaad Attia Abdel-Wahhab Employment: 1985-1989 : Assistant Researcher, Department of Food Technology, Food Technology and Nutrition Division, NRC. 1989-1990 : Researcher Assistant Present Department of Food Technology, Food Technology and Nutrition Division, NRC. 1990-1994 : Visiting Scientist, VAPH, Collage of Veterinary Medicine, Texas A&M Univer
PHARMACOLOGICAL THERAPY IN FIBROMYALGIA (Adapted from: Rao, S.G., Bennett, R.M. “Pharmacologic therapies in fibromyalgia”In Pain Best Practice & Research Compendium 2007) A wide variety of medications are used, with varying degrees of success, in the treatment of FMS, and severalexcellent articles have recently been published that review the efficacy of various agents in this syndr